` 603669 (Lionco Pharmaceutical Group Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

L
603669
vs
S
Shanghai Composite

Over the past 12 months, Lionco Pharmaceutical Group Co Ltd has underperformed Shanghai Composite, delivering a return of -33% compared to the Shanghai Composite's +15% growth.

Stocks Performance
603669 vs Shanghai Composite

Loading
603669
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
603669 vs Shanghai Composite

Performance Gap Between 603669 and SSEC
HIDDEN
Show

Performance By Year
603669 vs Shanghai Composite

Loading
603669
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Lionco Pharmaceutical Group Co Ltd vs Peers

Shanghai Composite
603669
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Lionco Pharmaceutical Group Co Ltd
Glance View

Market Cap
3.4B CNY
Industry
Pharmaceuticals

Lionco Pharmaceutical Group Co., Ltd. engages in the sale of chemical drug and antibiotic agents. The company is headquartered in Shannan, Xizang and currently employs 678 full-time employees. The company went IPO on 2015-05-28. is a China-based company principally engaged in the research and development, production and sales of chemical prescription medicine. The firm's products are mainly categorized in to three areas: parenteral nutrition agents, anti-infectious agents and digestive system agents. The lead product of its parenteral nutrition agents is Glutamine for injection; its anti-infectious agents include Cefodizime sodium for injection and Cefathiamidine for injection, among others; its digestive system agents include Omeprazole Sodium for injection and others. The firm operates its business in domestic market.

Lionco Pharmaceutical Group Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top